Santos-Palacios S, Brugos-Larumbe A, Guillen-Grima F et al 2013 a cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population. Clin Endocrinol (Oxf) ;79(6):874–881. https://doi.org/10.1111/cen.12216

Lee YK, Kim JE, Oh HJ et al (2011) Serum TSH level in healthy koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J Intern Med 26(4):432–439. https://doi.org/10.3904/kjim.2011.26.4.432

Article  PubMed  PubMed Central  Google Scholar 

Asvold BO, Vatten LJ, Nilsen TI et al (2007) The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT study. Eur J Endocrinol 156(2):181–186. https://doi.org/10.1530/eje.1.02333

Article  PubMed  Google Scholar 

Meisinger C, Ittermann T, Tiller D et al (2014) Sex-specific associations between thyrotropin and serum lipid profiles. Thyroid 24(3):424–432. https://doi.org/10.1089/thy.2013.0259

Article  PubMed  Google Scholar 

Ference BA, Ginsberg HN, Graham I et al 2017 low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J ;38(32):2459–2472. https://doi.org/10.1093/eurheartj/ehx144

Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet;366(9493):1267-78. https://doi.org/10.1016/s0140-6736(05)67394-1

LaRosa JC, Grundy SM, Waters DD et al (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352(14):1425–1435. https://doi.org/10.1056/NEJMoa050461

Stürzebecher PE, Katzmann JL, Laufs U 2023 What is ‘remnant cholesterol’? Eur Heart J ;44(16):1446–1448. https://doi.org/10.1093/eurheartj/ehac783

Varbo A, Nordestgaard BG (2017) Remnant lipoproteins. Curr Opin Lipidol 28(4):300–307. https://doi.org/10.1097/MOL.0000000000000429

Doi H, Kugiyama K, Oka H et al 2000 remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation ;102(6):670–676. https://doi.org/10.1161/01.cir.102.6.670

Castañer O, Pintó X, Subirana I et al 2020 remnant cholesterol, not LDL cholesterol, is Associated With Incident Cardiovascular Disease. J Am Coll Cardiol ;76(23):2712–2724. https://doi.org/10.1016/j.jacc.2020.10.008

Fu L, Tai S, Sun J et al 2022 remnant cholesterol and its visit-to-visit variability Predict Cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD Cohort. Diabetes Care ;45(9):2136–2143. https://doi.org/10.2337/dc21-2511

Huh JH, Han KD, Cho YK et al 2022 Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol ;21(1):228. https://doi.org/10.1186/s12933-022-01667-6

Huang H, Guo Y, Liu Z et al 2022 remnant cholesterol predicts long-term mortality of patients with metabolic dysfunction-associated fatty liver disease. J Clin Endocrinol Metab ;107(8):e3295–e3303. https://doi.org/10.1210/clinem/dgac283

Hu X, Liu Q, Guo X et al (2022) The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol 21(1):117. https://doi.org/10.1186/s12933-022-01554-0

Cao YX, Zhang HW, Jin JL et al 2020 the longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes. Cardiovasc Diabetol ;19(1):104. https://doi.org/10.1186/s12933-020-01076-7

Yuan L, Liu J, Huang Z et al 2023 elevated remnant cholesterol increase 6-year type 2 diabetes mellitus onset risk. Clin Chim Acta ;541:117253. https://doi.org/10.1016/j.cca.2023.117253

Chin J, Mori TA, Adams LA et al 2020 Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. JHEP Rep ;2(6):100150. https://doi.org/10.1016/j.jhepr.2020.100150

Roa Dueñas OH, Van der Burgh AC, Ittermann T et al 2022 thyroid function and the risk of Prediabetes and Type 2 diabetes. J Clin Endocrinol Metab ;107(6):1789–1798. https://doi.org/10.1210/clinem/dgac006

Paschou SA, Bletsa E, Stampouloglou PK et al 2022 thyroid disorders and cardiovascular manifestations: an update. Endocrine ;75(3):672–683. https://doi.org/10.1007/s12020-022-02982-4

Borges-Canha M, Neves JS, Mendonça F et al 2020 thyroid function and the risk of non-alcoholic fatty liver disease in morbid obesity. Front Endocrinol (Lausanne) ;11:572128. https://doi.org/10.3389/fendo.2020.572128

Ahi S, Amouzegar A, Gharibzadeh S et al 2017 the Association between normal range TSH and lipid Profile. Horm Metab Res ;49(6):424–429. https://doi.org/10.1055/s-0043-110142

Nordestgaard BG, Varbo A 2014 triglycerides and cardiovascular disease. Lancet ;384(9943):626–635. https://doi.org/10.1016/S0140-6736(14)61177-6

ElSayed NA, Aleppo G, Aroda VR et al 2023 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care ;46(Suppl 1):S19–S40. https://doi.org/10.2337/dc23-S002

Tognini S, Polini A, Pasqualetti G et al 2012 age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study. Thyroid ;22(11):1096–1103. https://doi.org/10.1089/thy.2012.0013

Gu T, Zhou W, Sun J et al 2018 gender and age differences in lipid Profile among Chinese adults in Nanjing: a retrospective study of over 230,000 individuals from 2009 to 2015. Exp Clin Endocrinol Diabetes ;126(7):429–436. https://doi.org/10.1055/s-0043-117417

Sun H, Zhu W, Liu J et al 2022 reduced sensitivity to thyroid hormones is Associated with high remnant cholesterol levels in Chinese euthyroid adults. J Clin Endocrinol Metab ;108(1):166–174. https://doi.org/10.1210/clinem/dgac523

McNamara JR, Shah PK, Nakajima K et al 1998 remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem;44(6 Pt 1):1224–1232

Wang Z, Chen Z, Zhang L et al 2018 Status of Hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation ;137(22):2344–2356. https://doi.org/10.1161/circulationaha.117.032380

Janovsky C, Goulart AC, Generoso G et al 2022 substantially elevated TSH, not traditional clinical subclinical thyroid disorder groupings, are associated with smaller LDL-P mean size: ELSA-Brasil. J Clin Lipidol ;16(3):335–344. https://doi.org/10.1016/j.jacl.2022.03.010

Xu C, Yang X, Liu W et al 2012 thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design. Nutr Metab (Lond) ;9(1):44. https://doi.org/10.1186/1743-7075-9-44

Chen MM, Huang X, Xu C et al 2022 high remnant cholesterol level potentiates the development of hypertension. Front Endocrinol (Lausanne) ;13:830347. https://doi.org/10.3389/fendo.2022.830347

Varbo A, Freiberg JJ, Nordestgaard BG (2018) Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the Copenhagen General Population Study. Clin Chem 64(1):219–230. https://doi.org/10.1373/clinchem.2017.279463

Li K, Fan F, Zheng B et al 2021 associations between remnant lipoprotein cholesterol and central systolic blood pressure in a Chinese community-based population: a cross-sectional study. Lipids Health Dis ;20(1):60. https://doi.org/10.1186/s12944-021-01490-0

Chan DC, Watts GF, Barrett PH et al 2003 relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clin Sci (Lond) ;104(4):383–388. https://doi.org/10.1042/cs1040383

Chan DC, Watts GF, Barrett PH et al 2002 markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem ;48(2):278–283

Ohnishi H, Saitoh S, Takagi S et al (2002) Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis 164(1):167–170. https://doi.org/10.1016/s0021-9150(02)00057-6

Nakajima K, Tokita Y, Tanaka A, Hypothesis (2018) Postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity. Clin Chim Acta ;485:126–132. https://doi.org/10.1016/j.cca.2018.06.029

Bakker SJ, ter Maaten JC, Popp-Snijders C et al 2001 the relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab ;86(3):1206–1211. https://doi.org/10.1210/jcem.86.3.7324

Rashid S, Watanabe T, Sakaue T et al 2003 mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem ;36(6):421–429. https://doi.org/10.1016/s0009-9120(03)00078-x

Pucci E, Chiovato L, Pinchera A (2000) Thyroid and lipid metabolism. Int J Obes Relat Metab Disord;24 Suppl 2S109–S112. https://doi.org/10.1038/sj.ijo.0801292

Pearce EN (2012) Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97(2):326–333. https://doi.org/10.1210/jc.2011-2532

Article  PubMed  Google Scholar 

Duntas LH, Brenta G (2012) The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 96(2):269–281. https://doi.org/10.1016/j.mcna.2012.01.012

Jung KY, Ahn HY, Han SK et al 2017 Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function. J Clin Lipidol ;11(6):1347–1353. https://doi.org/10.1016/j.jacl.2017.08.015

Hao QY, Gao JW, Yuan ZM et al 2022 remnant cholesterol and the risk of coronary artery calcium progression: insights from the CARDIA and MESA Study. Circ Cardiovasc Imaging ;15(7):e014116. https://doi.org/10.1161/circimaging.122.014116

Nordestgaard BG, Wootton R, Lewis B (1995) Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vasc Biol 15(4):534–542. https://doi.org/10.1161/01.atv.15.4.534

Varbo A, Benn M, Tybjærg-Hansen A et al 2013 elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation ;128(12):1298–1309. https://doi.org/10.1161/circulationaha.113.003008

Davies T, Marians R, Latif R (2002) The TSH receptor reveals itself. J Clin Invest 110(2):161–164. https://doi.org/10.1172/jci16234

Tian L, Song Y, Xing M et al 2010 A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology;52(4):1401-9. https://doi.org/10.1002/hep.23800

Song Y, Xu C, Shao S et al 2015 thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis. J Hepatol ;62(5):1171–1179. https://doi.org/10.1016/j.jhep.2014.12.006